Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

被引:4
|
作者
Chen, Xi [1 ]
Guo, Jishu [2 ]
Zhou, Fan [3 ]
Ren, Wenjun [4 ]
Huang, Xiaobin [1 ]
Pu, Jun [1 ]
Niu, Xiaoqun [5 ]
Jiang, Xiulin [6 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China
[2] Yunnan Univ, Inst forEcol Res & Pollut Control Plateau Lakes, Sch Ecol & Environm Sci, Kunming, Peoples R China
[3] Puer Peoples Hosp, Hematol & Rheumatol Dept, Puer, Peoples R China
[4] First Peoples Hosp Yunnan Prov, Dept Cardiovasc Surg, Kunming, Peoples R China
[5] Kunming Med Univ, Second Hosp, Dept Resp Med, Kunming, Peoples R China
[6] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
AL139385; 1; lung adenocarcinoma; prognosis biomarker; DNA methylation; ceRNA; cell proliferation; cell migration; CELL-PROLIFERATION; CANCER; RETRACTION; EXPRESSION;
D O I
10.3389/fonc.2022.905871
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan-Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan-Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Long non-coding RNA BRAF activated non-coding RNA as a potential novel molecular biomarker for metastasis and prognosis in various cancers
    He, Anbang
    Feng, Song
    Chen, Zhicong
    Liu, Yuhan
    Mei, Hongbing
    MINERVA MEDICA, 2017, 108 (03) : 293 - 298
  • [32] Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer
    Wu, B.
    Zhang, X. -J.
    Li, X. -G.
    Jiang, L. -S.
    He, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (17) : 3808 - 3812
  • [33] The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma
    Wang, Beiru
    Hou, Chengyu
    Yu, Xiang
    Liu, Jiaxin
    Wang, Jiyong
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [34] Long non-coding RNA HOTTIP, a novel potential prognostic marker in cancers
    Hu, Linhui
    Li, Manman
    Ding, Yangyang
    Pu, Lianfang
    Liu, Jun
    Xiong, Shudao
    MINERVA MEDICA, 2017, 108 (01) : 95 - 97
  • [35] Survival prediction model with long non-coding RNA profile in lung adenocarcinoma cancer
    Wang, Wei-An
    Lai, Liang-Chuan
    Tsai, Mong-Hsun
    Liu, Tzu-Pin
    Chuang, Eric Y.
    CANCER RESEARCH, 2015, 75
  • [36] Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma
    Li, Juan
    Li, Ping
    Zhao, Wei
    Yang, Rui
    Chen, Shanshan
    Bai, Yong
    Dun, Shaozhi
    Chen, Xiaonan
    Du, Yuwen
    Wang, Yuanyuan
    Zang, Wenqiao
    Zhao, Guoqiang
    Zhang, Guojun
    CANCER CELL INTERNATIONAL, 2015, 15
  • [37] A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma
    Chen, Mingwei
    Liu, Baoquan
    Xiao, Jianbing
    Yang, Yingnan
    Zhang, Yafang
    ONCOTARGET, 2017, 8 (09) : 14876 - 14886
  • [38] Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma
    Yu, Xiaolin
    Zhang, Yanxia
    ONCOLOGY LETTERS, 2020, 19 (04) : 2793 - 2800
  • [39] Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma
    Juan Li
    Ping Li
    Wei Zhao
    Rui Yang
    Shanshan Chen
    Yong Bai
    Shaozhi Dun
    Xiaonan Chen
    Yuwen Du
    Yuanyuan Wang
    Wenqiao Zang
    Guoqiang Zhao
    Guojun Zhang
    Cancer Cell International, 15
  • [40] Long non-coding RNA LOC541471: A novel prognostic biomarker for head and neck squamous cell carcinoma
    Wu, Hua
    Yu, Da Hai
    Wu, Mian Hua
    Huang, Teng
    ONCOLOGY LETTERS, 2019, 17 (02) : 2457 - 2464